Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation

Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH).

Massachusetts City Embraces The Decriminalization Of Psychedelics

Provincetown, Massachusetts has become the seventh municipality to join the growing movement towards decriminalizing psychedelics—plants and fungi. In a significant policy shift, the Provincetown Select Board voted this week

December 15, 2023

Lab group urges lawmakers to rescind FDA final rule on LDTs

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Association for Diagnostics and

September 9, 2024

Incyte gets another graft-versus-host disease drug approval, this time with partner Syndax

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.